Dalbavancin
Dalbavancin
Dalbavancin (pronounced dal-ba-van-cin) is a lipoglycopeptide antibiotic used in the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by certain susceptible bacteria, including Staphylococcus aureus and Streptococcus pyogenes.
Etymology
The name "Dalbavancin" is derived from the vancomycin, a similar type of antibiotic, and the prefix "dalba-" which is an arbitrary prefix.
Usage
Dalbavancin is administered intravenously and is often used when other antibiotics are ineffective. It works by interfering with the bacteria's cell wall formation, causing the cell wall to break down and eventually leading to the death of the bacteria.
Related Terms
- Lipoglycopeptide: A class of antibiotics that includes dalbavancin.
- Antibiotic: A type of drug used to treat infections caused by bacteria.
- Acute bacterial skin and skin structure infections (ABSSSI): A type of skin infection that dalbavancin is used to treat.
- Staphylococcus aureus: A type of bacteria that can cause skin infections and is susceptible to treatment with dalbavancin.
- Streptococcus pyogenes: Another type of bacteria that can cause skin infections and is susceptible to treatment with dalbavancin.
- Vancomycin: A similar type of antibiotic to dalbavancin.
External links
- Medical encyclopedia article on Dalbavancin
- Wikipedia's article - Dalbavancin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski